Chargement en cours...
Treatment of systemic-onset juvenile arthritis with canakinumab
Treatment of systemic-onset juvenile idiopathic arthritis is challenging, but the availability of cytokine antagonists targeting interleukin-1 and interleukin-6 have markedly advanced the therapeutic options. In this review, we focus on the current experience with canakinumab, an interleukin-1 monoc...
Enregistré dans:
| Publié dans: | Open Access Rheumatol |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5045123/ https://ncbi.nlm.nih.gov/pubmed/27790042 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OARRR.S54215 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|